Acute stressors can stimulate appetitive and exploratory behaviors, not just produce negative affect that impair performance. Corticotropin releasing factor (CRF), which is released in the brain in response to stress, acts on different targets and circuits to mediate both the negative and positive effects of stress. In the nucleus accumbens, CRF facilitates appetitive behavior through mechanisms not fully understood. Here we report that cholinergic interneurons (CINs) are a novel target for CRF actions in the striatum. CRF enhances the spontaneous firing via activation of CRF-type 1 receptors expressed on CINs. This causes the activation muscarinic acetylcholine receptors type 5, which mediate CRF potentiation of dopamine transmission in the striatum.
Introduction
CRF is a neuropeptide neuromodulator that is often released in response to salient environmental stimuli including acute stressors (Cook, 2004; Holly et al., 2016; Merali et al., 2004; Ohmura et al., 2009; Wang et al., 2005) . CRF has canonically been defined as the initiation factor of the hypothalamic-pituitary-adrenal (HPA) axis response (Bale, 2006; Bale and Vale, 2004) . It is densely expressed in the paraventricular nucleus of the hypothalamus (PVN) and triggers the release of ACTH from the anterior pituitary by activation of CRF-type 1 receptors (CRF-R1) (Bale and Vale, 2004; Nestler et al., 2002) . Both CRF and its two receptors, CRF-R1 and CRF-type 2 (CRF-R2) are widely distributed throughout the brain, beyond the hypothalamic area (Henckens et al., 2016; Justice et al., 2008; Kuhne et al., 2012; Steckler and Holsboer, 1999; Van Pett et al., 2000) . There is a rich literature investigating the actions of CRF in extrahypothalamic areas such as the amygdala, bed nucleus of the stria terminalis (BNST), locus coeruleus and dorsal raphe nucleus (DRN). Historically, little attention has been paid to the striatal complex owing to the relatively low expression levels of both CRF neuropeptide and receptors compared to the aforementioned areas (Henckens et al., 2016; Steckler and Holsboer, 1999; Van Pett et al., 2000) .
However, recent evidence suggests that CRF acting in the NAc can promote appetitive/approach behaviors including cue-triggered operant behaviors, novelty exploration and social affiliation behavior (Lemos et al., 2012; Lim et al., 2007; Pecina et al., 2006) . This behavioral effect of CRF has been linked to the in vitro observation that CRF can potentiate DA transmission in brain slices, suggesting CRF actions at the level of the dopamine terminals within the NAc. Further in vivo microdialysis experiments also suggest that CRF potentiates dopamine transmission in the NAc independently of actions at the cell soma (Chen et al., 2012; Lemos et al., 2012) . However, the mechanisms underlying this effect of CRF in the striatum remain unclear.
Microdialysis data has shown that CRF infusion into the NAc increases acetylcholine levels in the striatum, in addition to DA (Chen et al., 2012) . Over the last few years, we have gained further understanding on how acetylcholine can both trigger and modulate dopamine release through activation of nicotinic and muscarinic acetylcholine receptors respectively. Work from Dani and colleagues had demonstrated that electrically stimulated dopamine transients evoked in an ex vivo slice preparation were reduced following antagonism of β2-containing nAChRs (Zhang et al., 2004; Zhou et al., 2002) . It was subsequently demonstrated that optogenetic stimulation of CINs within the dorsal or ventral striatum evokes dopamine transients, and that this signal could be completely abolished by the nicotinic antagonists DhβE or mecamylamine (Cachope et al., 2012; Shin et al., 2017; Threlfell et al., 2012) . The kinetics of these events along with electron microscopy data supports a working model where β2-containing nAChRs localized along dopamine axons and terminals can depolarize these compartments and evoke DA release in response to acetylcholine release (Wonnacott et al., 2000) . Thus, synchronous firing of CINs can evoke DA release independently of the ventral tegmental area (VTA) or substantia nigra (SN) dopamine neuronal activity. Further, activation of muscarinic acetylcholine receptor can modulate DA transmission. Gi/o-coupled M2 and M4 receptors are expressed on striatal CINs and act as autoreceptors, suppressing both acetylcholine transmission and in turn, dopamine transmission (Shin et al., 2015; Threlfell et al., 2012; Yan and Surmeier, 1996) . In contrast, Gq-coupled M5 receptors localized to dopamine processes potentiates dopamine transmission (Schmidt et al., 2010; Shin et al., 2015; Zhang et al., 2002) . Based on these facts, we reasoned that CRF could enhance DA transmission by activating striatal CINs.
And indeed, an independent study demonstrated that stress-evoked dopamine transmission in the NAc was reduced by selective ablation of CINs in NAc (Laplante et al., 2013) . Thus, we sought to test this hypothesis directly by measuring the effects of exogenously applied CRF on the firing of CINs within the dorsal striatum (DS) and NAc. Moreover, we tested whether the CRF-mediated potentiation of DA transmission in the NAc was dependent on activation of either nAChRs or mAChRs.
Repeated exposure to stress or psychostimulant have been shown to alter the expression and/or function CRF peptide, CRF-R1 and CRF-R2 in a region dependent fashion (Curtis et al., 1995; Day et al., 1998b; Lemos et al., 2012; Liu et al., 2005; Reyes et al., 2006; Reyes et al., 2008; Waselus et al., 2009 ). We previously reported that repeated stress disrupts CRF's ability to enhance dopamine in the NAc. This cellular alteration was accompanied by a switch in the behavioral response to CRF directly infused into the NAc (Lemos et al., 2012) . In stress-naïve animals CRF produces a conditioned place preference suggesting that animals will bias their time allocation to contexts associated with endogenous CRF release specifically in the NAc. In contrast, animals subjected to repeated stressor exposure avoid contexts paired with intra-NAc infusion of CRF indicating a fundamental switch in the "perception" of CRF (Lemos et al., 2012 ).
Therefore, we tested the effects of CRF on cholinergic activity in both stress-naïve and stressexposed animals.
Results

CRF enhances CIN firing in DS and NAc
CINs make up only 1-2% of neurons within DS and NAc, which makes recording from these neurons in a high throughput fashion challenging. To aid with visualization of striatal CINs, recordings were carried out in ChAT-ires-Cre +/-mice crossed with the Cre-reporter mouse line Ai14 tdTomato (CIN-reporter). We confirmed that red fluorescently-labeled Cre+ cells showed immunoreactivity for choline acetyltransferase (ChAT) and displayed the classic electrophysiological and morphological properties of CINs (i.e. spontaneously active, IH sag, accommodation and large soma) (SF1). As seen in many other spontaneously active neurons, CINs showed a "run-down" of the spontaneous firing whole-cell configuration, due to the dialysis of the cytoplasm by the internal solution. For this reason, the majority of electrophysiological recordings were conducted in cell-attached configuration with gigaOhm seal maintained throughout the recording.
Bath application of CRF (100 nM) on to the brain slices significantly increased the spontaneous firing of CINs in both the NAc and DS (combined dorsolateral and dorsomedial) (NAc: 2.6 Hz to 6.2 Hz; DS: 0.7 Hz to 2.7 Hz, 2-way RM ANOVA, main effect of drug: F1,19 = 99.83
, post-hoc Sidak's t-tested, ps < 0.0001, n = 10-12, Figure 1a ,b). When normalized to baseline, CRF increased CIN firing by 253 ± 22% and 507 ± 96% of baseline for the NAc and DS respectively (Figure 1c, d Qualitatively, it appeared that cells with lower firing rates at baseline had larger CRF-mediated increases in firing. To formally assess this negative correlation, we plotted the magnitude of the CRF effect in percent as a function of the baseline firing rate in Hz on a semi-log plot (Figure 1e ).
This analysis yielded an R 2 value of 0.51 suggesting that baseline firing rate accounts for approximately 50% of the size of CRF's potentiation of CIN firing. Next, we assessed the concentration dependence of the CRF effect was assessed next in NAc CINs. For this, we screened cells with baseline firing rates between 1 and 5 Hz, which provided similar average baseline firing rates across the experiments with different CRF dose ( Figure 1f ). The CRF concentration dependence curve can be fitted to sigmoidal equation with EC50 of 8.7 nM, demonstrating the high sensitivity of this novel mechanism of CRF action in the striatum ( Figure   1g ,h).
CRF-R1 receptors are required and are expressed in CINs
A combination of RNAscope in situ hybridization and pharmacology was used to identify the receptor subtype responsible for the CRF-mediated increase in CIN firing. RNAscope in situ hybridization was performed on thin brain sections (16 µm) containing the DS and NAc in which a probe against ChAT (CIN) mRNA was multiplexed against probes for either crh1 (CRF-R1), crh2 (CRF-R2) or crh (CRF) mRNA. Three to four sections from 3 animals were imaged using confocal microscopy and a combination of automated and manual analysis was performed using Fiji/ImageJ software. Cells showing at least five labeled puncta tightly clustered around the nucleus were considered positive for CRF-R1, R2 or CRF. The analysis showed that 92% and 90% of ChAT positive neurons contained CRF-R1 mRNA in the NAc and DS respectively ( Figure   2a ,b, SF2). In contrast, there was no evidence of co-localization of CRF-R2 or CRF mRNA with
ChAT mRNA in either the NAc or DS (Figure 2a-d, SF2 ).
There is a substantial literature indicating that the CRF-R1s are expressed in cholinergic projection neurons of the basal forebrain (Sauvage and Steckler, 2001) . As a control, we also quantified labeling in the basal forebrain of the same tissue sections. Analysis of ChAT+ neurons in the diagonal band area where most cholinergic neurons that project to the hippocampus are found (Ballinger et al., 2016) , showed 45% of ChAT+ cells were also co-labeled for CRF-R1 mRNA while only 1% were co-labeled for CRF-R2 mRNA (SF2). Thus, to our surprise, expression of CRF-R1 is even more prominent and robust on CINs within the striatum than on cholinergic neurons in the basal forebrain.
We also observed CRF-R1 mRNA expression in cells that did not express mRNA for ChAT in both the DS and NAc. 18% of all DAPI labeled cells were positive for CRF-R1 receptors in both the DS and NAc (Figure 2e,f) . The presence of cells expressing mRNA for CRF-R2 was negligible in the DS (<1%). However, in the NAc, 4% of cells were positive for mRNA for CRF-R2 ( Figure   2e ,f). Future work will be needed to determine the identity of those cells that are presumed noncholinergic neurons based on undetectable mRNA for ChAT and that are shown to express mRNA for CRF-R1 and R2.
With regard to the expression of mRNA for the neuropeptide itself, we found that 5% of cells in the NAc showed labeling for mRNA for CRF, but no cells were found in the DS ( Figure   2g ). In contrast, cells in PVN, BNST, and CeA showed robust expression of CRF mRNA using the same RNAscope probe (SF3). Notably, the lack of localization of mRNAs for CRF and ChAT is contrary to our previous finding of co-localization of immunostaining for CRF and ChAT (Lemos et al., 2012) .
Given the strong evidence for the expression of CRF-R1 in CINs, we hypothesized that activation of CRF-R1 was required for the CRF-mediated increase in firing of CINs. For the remainder of our experiments, we focused our analysis on the neurons in the NAc and tested the ability of the selective antagonists for CRF-R1 (NBI 35695) and for CRF-R2 (Astressin 2B) to block the CRF effect. Slices were pre-incubated with either antagonist for at least 20 minutes and maintained in the antagonist for the duration of the experiment. In the presence of NBI 35695 (1 µM), CRF failed to increase CIN firing frequency. We also tested a different R1 antagonist, CP 154,526 (1 µM) which also reduced the effect of CRF, but did not block it completely. In contrast, Astressin 2B (300 nM) had no effect on the potentiation by CRF (295% increase from baseline) (NBI: 2.6 Hz to 2.2 Hz; Astressin 2B: 2.1 Hz to 4.8 Hz, 2-way RM ANOVA, interaction: F1,11 = 47.27, post-hoc Sidak's t-test for AS2B, p < 0.0001, n = 6-7, Figure 3a CRF-R1 activation engages the Gαs signaling pathway in other cell types (Hauger et al., 2006) . Recruitment of Gαs can initiate cAMP-dependent recruitment of both protein kinase A and other effectors such as guanine nucleotide exchange factors (EPACs). We used a cAMP analogue Rp-cAMPs (100 µM) was included in the internal solution and allowed to dialyze into the cell; this treatment blocks endogenous cAMP signaling. Under these conditions, CRF failed to increase the AP frequency (2-way RM ANOVA, interaction: p's = 0.9778, 0.7804, 0.9857; main effect of CRF: p's = 0.6307, 0.4869, 0.6159 for the full 800 ms, the first 400 ms, the last 400 ms, respectively; n = 7, Figure 4g , SF4). When we directly inhibited PKA with PKI 14-22, CRF still significantly increased the AP frequency during the first 400 ms (2-way RM ANOVA, interaction: ps = 0.0001, 0.0002 respectively, n = 8, Figure 4h , SF4), but failed to increase during thelast 400 ms (2-way RM ANOVA, interaction: p = 0.2527; main effect of CRF: p = 0.0732, n = 8, Figure 4n , SF4). These data indicate that while activation of PKA may contribute modestly to CRF's ability to increase CIN firing, cAMP activation is required for the CRF effect on CINs.
We also tested two different PKC inhibitors, chelrythrine ( Taken together, these data indicate that CRF enhances CIN firing through multiple effectors, all of which rely on cAMP. The effect of CRF seems to be particularly prominent when measuring the AP frequency when the depolarization induced block common to CINs is most apparent. PKA and Ih may play a modest role and may be necessary in order for CRF to achieve and its typical reliable and maximal effect size, however it is not required for the effect to occur.
Based on both the cell-attached voltage clamp and current clamp experiments, it does not appear that the CRF-mediated increase in CIN firing frequency is reliant on PKC activation ( Figure 4k ).
CRF potentiation of DA transmission does not require nicotinic acetylcholine receptors
Given the profound effect of CRF on CIN firing frequency, we hypothesized that the potentiation of DA transmission by CRF is mediated by activation of acetylcholine receptors on the axons of DA neurons. Thus, we predicted that blockade of nicotinic receptors with the β2 nAChR antagonist DHβE would block CRF potentiation of electrically evoked DA transient (eDA).
Using fast scan cyclic voltammetry (FSCV) in the same ex vivo slice preparation, we replicated the main finding that CRF increases the peak dopamine transient by 21 ± 4% above baseline (one-sample t-test vs. 0, p = 0.003, n = 16, Figure 5a , SF5). More importantly, CRF potentiation was significantly greater than vehicle control (2-way RM ANOVA, interaction of CRF vs. VEH, F13,338 = 5.014, p < 0.0001, n = 12-16, Figure 5a ).
Application of DHβE (1 µM) alone reduced the amplitude of eDA by more than 50% of the baseline, isolating the component of DA transient evoked by direct electrical stimulation of DA axon fibers in the striatum (Zhang et al., 2002; Shin et al., 2015) . However, CRF still potentiated eDA by 34 ± 5.6% in the presence of DHβE (one-sample t-test vs. 0, p < 0.0001, n = 16, 2-way RM ANOVA vs. VEH, interaction: F13,273 = 7.082, p < 0.0001, n = 7-16, Figure 5b , SF5). This potentiation by CRF in DHβE was modestly enhanced compared to ACSF at some time points although this was not significant when assessing the collapsed maximal effect (unpaired t-test, p = 0.07, SF5). When we probed this further using electrical stimulation of a train of 5 pulses at 10
Hz, a stimulation closely resembling in vivo phasic DA transmission, the potentiation by CRF was significantly enhanced in DHβE compared to ACSF (SF5, Supplementary Results & Discussion).
As a control, we demonstrated that incubation in DHβE did not alter the maximal CRF mediated increase in CIN firing frequency, though the time to maximal effect was slightly delayed (in DHβE: baseline: 2.45 ± 0.26 Hz, CRF: 5.71 ± 0.46 Hz, p < 0.0001; 2-way RM ANOVA compared to in ACSF, F27,567 =2.62, p < 0.0001, n = 14, Figure 5c -e).
We have previously shown that CRF-mediated potentiation of DA transients is blocked by pre-treatment with the CRF-R1 antagonist (Lemos et al., 2012 ). Here we then tested whether this same CRF-R1 antagonist could reverse the potentiation after CRF application. Interestingly, we found that the CRF-R1 antagonist CP 154,526 (1 µM) could not reverse the CRF-mediated potentiation of eDA, even after an hour of CRF washout and CRF-R1 antagonist chase (SF6).
This data suggests that CRF may initiate a long-lasting change in the striatal circuitry that triggers a long-term potentiation-like effect on DA transmission.
CRF potentiation of dopamine transmission is dependent on M5 receptor activation
We and others have previously shown that muscarinic M5 receptors potentiate dopamine transmission, particularly when triggered by activation of dopamine fibers optogenetically or by pharmacological isolation (Schmidt et al., 2010; Shin et al., 2015; Zhang et al., 2002) . In this study, we replicated these findings (SF7, see Supplementary Results & Discussion). We then tested whether the activation of mAChR is required for CRF-mediated potentiation of DA transients. Scopolamine (1 µM), a non-selective mAChR antagonist, reduced the CRF-mediated potentiation by 50%, both in control ACSF and in DHβE conditions (in ACSF + SCOP, CRF vs.
VEH: 2-way RM ANOVA, interaction: F13,386 = 2.158, p = 0.01, n = 6-16, Figure 5f,j; in DHβE+SCOP: 2-way RM ANOVA, interaction: F13,281 = 4.567, p < 0.0001, n = 11-13, Figure 5k ).
While smaller, CRF still showed a significant potentiation of eDA compared to vehicle. These data suggest that activation of muscarinic receptors mediates a large part, but not all of, the CRF potentiation of DA transmission.
In mice with constitutive genetic deletion of M5 mAChR (M5KO), CRF enhanced dopamine transient amplitude compared to vehicle application but did so less than in slices from control mice and to a similar degree as seen in the presence of the non-selective muscarinic receptor blocker scopolamine (control = 20.6 ± 4.4% , M5KO= 8.25 ± 2.6%; SCOP= 7.85 ± 2.2%, Altogether, these findings provide evidence for the existence of two independent mechanisms for CRF-mediated potentiation of DA transmission, one that requires activation of M5 mAChR receptors and a small one independent of muscarinic receptor activation that is likely mediated by CRF receptors on dopamine terminals, based on anatomical data (Lemos et al., 2012) . We tested whether CRF effect on CIN firing frequency also required muscarinic receptor activation and found that CRF still increase CIN firing in the presence of scopolamine (from 2.8 ± 0.35 Hz at baseline to 5.3 ± 0.38 after CRF, p < 0.0001, n = 11, Figure 5g ,h), and to a comparable degree to the CRF effect in ACSF (2-way ANOVA, interaction, p = 0.2181). Thus, these data indicate that the requirement for muscarinic receptors is downstream of the CRF actions on CIN firing and it suggests that the M5 mAChR receptors that contribute to the CRF potentiation of DA transmission are localized to DA axon projections and/or terminals, in agreement with previous work (Shin et al., 2015) .
Repeated stress differentially affects CRF function and mRNA expression based on cell type
Stressor exposure has been shown to alter the mRNA expression, protein distribution and function of CRF and its two receptors (Milan-Lobo et al., 2009; Reyes et al., 2008; Waselus et al., 2009 ). We conducted a series of studies where we probed CRF function as well as mRNA expression of Crh and Crh1 in animals exposed to repeated stress (FSS) and compared them to naïve mice kept in homecage (Figure 6a ; Ai14 tdTomato) were exposed to two days of repeated swim stress and studied 7 days after last stressor exposure (Figure 6b ). Slices containing the NAc were prepared and half were used for DA transient measures using FSCV and the other half were used for cell-attached electrophysiology recordings from CINs, providing an internal control for CRF function on the two effectors ( Figure 7b ). The results of the FSCV experiments replicated previous findings showing that exposure to repeated swim stress caused a persistent reduction of CRF-mediated potentiation of eDA. The maximal CRF effect was 20.5 ± 3.6 % increase in naïve mice while there was only a 11.6 ± 2.5% increase in animals that underwent FSS (unpaired t-test, p = 0.048, n = 7-11; Figure 6d ,e). We hypothesize that the reduction could be due to selective loss of one of the two independent mechanisms of CRF action: the M5-dependent or the M5-independent mechanism. We tested the direct effect of a muscarinic agonist oxotremorine (Oxo-M) on slices from naïve and FSS animals in the presence of DHβE to avoid cross talk between ACh receptors.
In naïve animals, application of Oxo-M produced an increase of 14 ± 4%. in the steady state amplitude of eDA transient. Subsequent application of CRF further increased eDA to 29.1 ± 4.6% from initial baseline, revealing an M5-independent component of around 15% (Figure 6f ), in agreement with data from Figure 5 showing approximately 50:50 contribution of each mechanism.
In slices from FSS animals, Oxo-M still produced an increase in eDA transient amplitude with similar early rise of 24 ± 3% (compared to 22 ± 2% in naïve) and a steady state increase of 10 ± 4.5 % (compared to 14% in naïve; Figure 6f ). There was no statistical difference between the groups (2-way RM ANOVA, post-hoc t-test, p = 0.99). However, in FSS group, subsequent application of CRF failed to further increase eDA amplitude (4 ± 5 % in FSS compared to 16 ± 5% in naïve from amplitude in Oxo-M, n = 8-10;2-way RM ANOVA of FSS vs. naïve, interaction: F22,352 = 2.65, p = 0.0001, post-hoc t-test, p = 0.02, Figure 6f ). These results strongly suggest that exposure to repeated stress selectively impairs the M5-independent component of CRF action while sparing the M5 dependent component intact.
In agreement with this interpretation, we found that prior stressor exposure did not alter the CRF-mediated increase in CIN firing (267 ±19% in FSS vs 273 ± 22% in naïve, n = 8-14; unpaired t-test, p = 0.8637, 2-way RM ANOVA no interaction: F27,540 = 0.7259, p = 0.8433, Figure   6g ,h). Thus, altogether the findings suggest no changes to the function/signaling of CRF-R1 receptors on CINs nor M5 receptor on dopamine terminals. These led us to speculate that stress exposure induces changes in the function and/or expression of CRF-R1 receptors expressed on DA neurons and/or terminals, which we inferred mediate the M5-independent mechanisms of CRF action. Possible changes in receptor expression were assessed using RNAscope method using probes for the CRF-R1 mRNA, Crh1, in both the NAc and VTA. We also assessed the expression of the CRF peptide itself using primers for Crh mRNA. Note that, in agreement with a previous report (Grieder et al., 2014) , we found that 17% of TH+ neurons were also positive for Crh mRNA.
For Crh1 mRNA coding for CRF-R1 receptor, we quantified its expression in TH+ cells within the VTA and in ChAT+ CINs in the NAc using a multiplexing approach in which the three hybridization probes (ChAT, TH and Crh1) were tested in the same sagittal brain section in order to more reliably compare differences in expression across brain areas. In the VTA, contrast to our hypothesis, exposure to prior stressor significantly increased both the number of CRF R1+/TH + cells (naïve: from 78% in naïve to 86% in FSS, p = 0.03, Figure 7o -r) and the number of puncta per TH+ cell (naïve= 32 ± 1 puncta; FSS= -48.4 ± 1.3, n= 160-160 TH+ cells, p < 0.0001, Figure   7p ,q). In the NAc, there was no differences in the number of Crh1 mRNA puncta per CIN cell (naïve= 21 ± 1 puncta; FSS = 25 ± 1.5, n= 67-71 ChAT + cells, p = 0.0589, Figure 6o -r).
Thus, we find exposure to repeated stress lowers the CRF-mediated potentiation of DA transmission in the accumbens by selectively affecting the M5-independent mechanism of CRF actions. As far as can be determined by our experiment, stress spares the CRF effect on CIN firing, and also the downstream potentiation of dopamine transmission mediated by muscarinic M5 receptors. Stress then produces selective alterations to CRF targets, even within the same region on the brain. It has been shown that CRF-R1 receptor can internalized upon agonist exposure (Reyes et al., 2006 ) and thus we speculated that prolonged CRF release during repeated stress could also trigger receptor internalization. We hypothesized that there may be a disruption of CRF receptor function due to increased CRF release in the NAc. While it is very difficult to assess CRF release directly, we were able to assess changes in CRF mRNA expression following repeated swim stress. We posited, based on previous anatomical work (Lemos et al. 2012) , that the M5-independent component is mediated via CRF receptors localized to DA terminals. An additional explanation for the absence of the M5-independent component in the FSS group is through downregulation of CRF R1 function or expression at DA terminals.
Discussion
Novel CRF effector within the striatum: cholinergic interneurons
This study identifies a novel CRF effector within the dorsal and ventral striatum. A few previous reports showed sparse expression of CRF receptors in the striatum, (Henckens et al., 2016; Justice et al., 2008; Kuhne et al., 2012; Van Pett et al., 2000) but the cellular identity of this expression had not been addressed. Here we report that CRF-R1 receptors are expressed on CINs in the DS and NAc and that CRF robustly and reliably increases the spontaneous firing of action potentials in these neurons. The effect of CRF on CINs requires cAMP production and could involve suppression of spike accommodation. We propose that this novel effect of CRF might represent the underlying mechanism for a previously published effect of CRF in the NAc where elevation of ACh extracellular levels was seen in response to CRF (Chen et al. (2012) ). In addition, our study provides evidence that this novel CRF action on CINs contributes to the CRFmediated potentiation of DA transmission in the striatum.
CRF indirectly activates ACh muscarinic M5 receptors to potentiate dopamine transmission
Our findings indicate that CRF potentiates dopamine transmission via two independent mechanisms: a) one that requires activation of ACh muscarinic M5 receptors and b) an M5-independent mechanism. Both these mechanisms required activation of CRF-R1 receptors, but we speculate that each requires the activation of CRF-R1 receptors expressed on different celltypes. Based on the in situ hybridization findings showing expression of crh1 (the coding for CRF-R1 receptors) in the CINs and the pharmacological data, we speculate that activation of CRF-R1 receptors on CINs causes the increase in spontaneous firing that increases the extracellular levels of Ach which in turn activate muscarinic M5 receptors on DA neuron axon terminals to potentiate DA transmission (Figure 7) . Our model also posit that the M5-independent mechanism is mediated via CRF-R1 receptors on dopamine terminals that could directly potentiate DA transmission. CRF-R1 receptors are localized to DA fibers based on both immunohistochemistry and electron microscopy data (Lemos et al., 2012) .
CRF increases CINs firing and facilitates cholinergic transmission in the striatum
Acetylcholine release from the basal forebrain versus the striatum supports different, and in some cases opposite behaviors. Both stress and centrally (i.c.v.) administered CRF stimulate acetylcholine release in the hippocampus via activation of CRF-R1 receptors on cholinergic basal forebrain diagonal band projection neurons (Day et al., 1998a; Day et al., 1998b; Fernandes et al., 2018; Sauvage and Steckler, 2001 ). Moreover, this enhanced cholinergic transmission and nicotinic receptor activation in the hippocampus can lead to an increase in anxiety-and depression-like behavior (Fernandes et al., 2018; Mineur et al., 2013) . Acetylcholine transmission in the striatum subserves a diverse set of behavioral responses that are dependent on the striatal subregion (i.e. NAc, DLS, DMS) and context in which ACh levels or CIN firing is being assessed.
There is evidence that enhanced cholinergic signaling encodes salience regardless of valence and reflects reward prediction errors by shifting from a tonic to burst/pause mode (Deffains and Bergman, 2015) . It has also been shown that modulation of CIN firing can support both approach or withdrawal behavior (Grasing, 2016; Hoebel et al., 2007) , is important for reinforcement learning and for cognitive and behavioral flexibility (Aoki et al., 2018; Prado et al., 2017; Ragozzino, 2003) . Here we show that CRF enhances CIN firing frequency regardless of region.
Thus, we propose CRF acts to potentiate striatal ACh-dependent behaviors and that the specific behavior to be facilitated will depend on the striatal subregion where CRF is released. For example, we present evidence confirming that CRF peptide is present in a significant percentage of NAc neurons, but not DS neurons ( Figure 2 ) and also (Merchenthaler, 1984; Peng et al., 2017) .
Thus, in the context in which CRF is released from these NAc CRF cells, we would predict that CRF would potentiate appropriate NAc-dependent ACh-dependent responses. This prediction should be directly tested in future studies.
CRF receptors were shown to couple to different G proteins depending on cell-type and agonist concentration. Here we showed that the CRF mediated increase in CIN firing requires cAMP production. Yet there was only a nominal effect of PKA or PKC inhibition on CRF's ability to increase firing frequency. It is possible that CRF is exerting its effect on CIN firing through a cAMP dependent, but PKA independent mechanism. Indeed, there have been recent reports that CRF receptors can couple to EPAC2 (a guanine nucleotide exchange factor for the Ras-like small GTPases) in a cAMP dependent fashion (Smani et al., 2010; Traver et al., 2006; Van Kolen et al., 2010) . EPACs have been shown to modulate the function of several different ion channel types including L-type calcium channels, AMPA receptors and voltage-gated potassium channels (Liu et al., 2016; Roscioni et al., 2008; Smani et al., 2010; Stott et al., 2016) . Thus, it is plausible that CRF-R1 is stimulating EPACs to effect ion channel conductance and in turn firing frequency at one of these effectors.
.
Repeated stress exposure selectively alters ACh-independent mechanisms and the expression of CRF receptor in the DA neurons but not CINs
Stress exposure produces plasticity in the CRF system that includes changes in peptide expression, effector coupling and function. CRF modulates the activity of dopamine, serotonin and norepinephrine neurons (Beckstead et al., 2009; Chen et al., 2012; Kirby et al., 2008; Kuhne et al., 2012; Lemos et al., 2012; Price et al., 2002; Riegel and Williams, 2008; Ungless et al., 2003; Valentino et al., 1983; Wanat et al., 2013; Wanat et al., 2008) as well as cholinergic neurons in basal forebrain, which mediates release of acetylcholine into the hippocampus (Day et al., 1998a) . Prior stress history differentially affects the function of CRF at these different cellular substrates. For example, both stressor exposure as well as basal stress hyperresponsivity ablate the ability of CRF-R1 to increase GABAergic transmission onto serotonergic dorsal raphe neurons (Lamy and Beck, 2010; Lemos et al., 2011) , thereby reducing CRF mediated-inhibition of serotonin release. Likewise, different types of stressor were shown to disrupt CRF's ability to enhance dopamine transmission both in the VTA and the NAc (Beckstead et al., 2009; Lemos et al., 2012) , an effect that our findings here confirm and extend upon. In contrast, stressor exposure potentiates the CRF-mediated increase in noradrenergic LC firing rates, particularly at lower concentrations, and potentiates the CRF-mediated increase in acetycholine release in the hippocampus (Day et al., 1998a) .
Understanding the precise changes to the CRF system caused by stress exposure as well as the underlying mechanism by which this take place, has been complicated by the fact the direct comparison across different stress paradigms, species and preparations are not possible. In this study, we compared the effect of exogenously applied CRF at a given concentration (100 nM) on two different CRF effectors within the same animals in the same region. We found that while one effector is clearly disrupted following stressor exposure, the other is kept intact. These data support the notion that stress-induced plasticity of CRF function occurs in cell-type specific manner presumably to adaptively shift behavior responsivity. This main conclusion is consistent with recent work demonstrating that CRF-R1 deletion selectively in dopamine neurons leads to anxiogenic-like behaviors while CRF-R1 deletion in glutamatergic neurons produces anxiolyticlike responses (Refojo et al., 2011) .
Collectively, the broad distribution of CRF-R1 expression to different cell-types, the different functional and behavioral consequences of CRF-R1 activation and the different sensitivity to stress-exposure by the individual CRF targets all point to the overall conclusion that the CRF system is quite complex and CRF release in different brain regions would trigger different behavioral responses, even when all mediated by the same receptor type, CRF-R1 in this case.
In light of these data, it is logical to predict that no classical pharmacological manipulation that targets all CRF-R1 receptors would be ideal for treating stress-induced mood disorders. We propose that targets downstream of the CRF-R1 activation could offer more selectivity. For example, the M5 receptor is an interesting target for potential therapeutic actions, which unlike other muscarinic receptors it has quite restricted expression. Our data suggests that deletion of M5 receptors very selectively impairs the CRF actions on dopamine transmission. It is possible that boosting M5 receptor activity, e.g. with a positive allosteric modulator or partial agonist, would have therapeutic value by ameliorating some stress-induce impairments of dopamine-dependent behaviors such as exploratory and appetitive behaviors.
Future Directions
There are many new avenues to pursue and follow up on from this first study. Perhaps the most pressing and obvious question is how CRF ultimately affect the excitability, firing and output of medium spiny projection neurons, which make up 95% of striatal neurons and constitute the output of sensory, motor and limbic integration from the striatum. There have been two reports that indicate that CRF enhances both c-fos immunoreactivity and phospho-CREB activity in striatal neurons (Pecina et al., 2006; Stern et al., 2011) . It is still unknown (1) whether this connection is mediated through neuromodulation by DA and/or ACh, (2) whether this leads to changes in excitability and output of MSNs, and (3) finally whether it is selective for direct or indirect pathway MSNs. These are the next critical questions, which answers will further our understanding of CRF modulation of striatal circuit function and its behaviors. 
Experimental Procedures
All procedures were performed in accordance with guidelines from the Animal Care and Use
Committee of the National Institute on Alcohol Abuse and Alcoholism. Image analysis and quantification: Sections were imaged using a Zeiss confocal microscope and Zen software. Unique 20x (5 µm thick) and 40x images (2 µm thick) were acquired from DS, NAc and VTA of stress-naïve and stress-exposed mice using the same software and hardware settings. The settings were titrated for each specific experimental probe. Quantification was done using Fiji/ImageJ software. Numbers of DAPI cells were automatically generated using the particle counter function in ImageJ. Numbers of ChAT cells and ChAT+/CRF-R1, +R2 or +CRF positive cells were manually counted using the cell counter function. For both ChAT and DAPI cells, cells were considered positive for the experimental probe, if there >5 particles clustered around (but not in) the cell nucleus. Numbers of puncta per ChAT (67-71 unique cells for naïve and stressexposed mice) or TH (160 unique cells for naïve and stress-exposed mice each) cell was analyzed in a semi-automated fashion and this process is represented in SF9. Masks were generated using the ChAT or TH positive cell as a reference point. Rather than using the outline of the cell itself, we used a uniform circle that was the approximate size of the soma and this was kept consistent throughout the analysis. The fluorescent image of the experiment probe, in this case Mm-Crh1 or Mm-Crh, was converted into a binary image after being thresholded. The thresholding was kept consistent across images. Finally, the mask generated with the cell maker image was combined with the binary image of the experimental probe. This generated an image with only the puncta around the soma of our cells of interest were present. We then used the particle analyzer function to automatically count number of puncta.
In vitro electrophysiology: Coronal slices (240 µm) containing the DS and NAc core were prepared from 8-16 week-old mice ChAT-ires-CRE +/-;Ai14 tdTomato mice. Slices were cut in icecold cutting solution (in mM): 225 sucrose, 13.9 NaCl, 26.2 NaHCO3, 1 NaH2PO4, 1.25 glucose, 2.5 KCl, 0.1 CaCl2, 4.9 MgCl2, and 3 kynurenic acid. Slices were maintained in oxygenated ACSF containing (in mM): 124 NaCl, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 26.2 NaHCO3, 1 NaH2PO4, and 20 glucose (~310-315 mOsm) at RT following a 1hr recovery period at 33⁰C. Cell-attached recordings in voltage clamp mode were performed to measure the effect of CRF on CIN firing frequency. For cell-attached recordings, electrodes were filled with filtered ACSF (the same that was used for external solution). A gigaohm seal was achieved, maintained and monitored. Cells in which the gigaohm seal had degraded were excluded. Current clamp recordings were performed using electrodes (2.5-4 MΩ) filled with 120 KMeSO4, 20 KCl, 10 HEPES, 0.2 K-EGTA, 2 MgCl2, 4 Na-ATP, and 0.4 Na-GTP (pH = 7.25, ~290 mOsm). Data were acquired at 5 kHz and filtered at 1 kHz using Multiclamp 700B (Molecular Devices). Data was analyzed using pClamp (Clampfit, v.
10.3).
Fast scanning cyclic voltammetry: Brain slices from C57BL6/J, M5KOor ChAT-ires-CRE +/ ;Ai14 tdTomato mice were prepared as described in the electrophysiology section using the same external solution and cutting solution. Carbon fiber (7 μm diam., Goodfellow) electrodes were fabricated with glass capillary (602000, A-M Systems) using a Sutter P-97 puller and fiber tips were hand cut to 100-150 μm past the capillary tip. Immediately prior to the experiments they were filled with 3M KCl internal solution. The carbon-fiber electrode was held at −0.4 V and a voltage ramp to and from 1.2 V (400V/s) was delivered every 100 ms (10 Hz). Before recording, electrodes were conditioned by running the ramp at 60 Hz for 15 min and at 10 Hz for another 15 min and calibrated. Electrodes were calibrated using 1 µM DA. DA transients were evoked by electrical stimulation delivered through a glass microelectrode filled with ACSF. Either a single monophasic pulse (0.2 msec, 300 µA) or trains of pulses (5 pulses at 5, 10, 25, 100 Hz) was delivered to the slice in the absence or presence of the nAChR antagonist DhβE (1 µM). For optogenetic experiments, light stimulation was delivered through optical fiber (0.6 msec, ~700 µW). Data was acquired with a retrofitted headstage and Axon Amplifier using Multiclamp.
Voltammetric analysis was done using custom written procedures in Igor Pro software. The voltamogram, peak amplitude, and area of the DA transient were measured. Experiments were rejected when the evoked current did not have the characteristic electrochemical signature of DA assessed by a current-voltage plot.
Behavior:
Forced Swim Stress: Mice were moved to behavioral suite and allowed to acclimate for at least 30 min. The swim stress procedure was done as described in (Lemos et al., 2012) . Briefly, animals are placed in a 20 cm cylinder filled with 4L of water maintained at 30 ± 1ºC for 15 mins on Day 1
and 4 x 6 min on Day 2, separated by 6 min intervals in their homecage. Animals are returned to their homecage for 7 days and then ex vivo slices are prepared.
Statistics:
Statistical analysis was performed in Prism (GraphPad) and Excel. Unless stated, twotailed unpaired t-test was used. Otherwise, two-tailed paired t-test, 1W ANOVAs or 2W Repeated
Measures (2WRM) ANOVAs or one-tailed t-tests were used when appropriate and stated. 2W
ANOVAs were followed up with a Dunnett's or Sidak-corrected t-test comparisons. All data are presented as mean ± SEM. Results were considered significant at an alpha of 0.05. Figure 7
